Estimating Venous Thromboembolism Risk in Metastatic Colorectal Cancer Inpatients: Validation of Existing Risk Scores and Development of New Risk Scores.

Clin Appl Thromb Hemost · 2023 · PMC10498692 · PMID 37691565

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Patients with KRAS / NRAS mutations exhibited a low incidence of VTE, while those with BRAF mutations showed a high incidence; however, the observed difference did not reach statistical significance, likely due to the limited sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.